FdaApplication
NDA 212295
Identifiers
- fda_app_no: NDA212295
Properties
| Property | Value |
|---|---|
| applicant_name | ACACIA PHARMA LTD |
| application_type | NDA |
| approval_date | 2020-10-06 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BYFAVO | REMIMAZOLAM BESYLATE | EQ 20MG BASE/VIAL | POWDER;INTRAVENOUS |
1 product